Cargando…

Radiofrequency ablation for Barrett’s oesophagus related neoplasia with the 360 Express catheter: initial experience from the United Kingdom and Ireland—preliminary results

BACKGROUND: Radio-frequency ablation (RFA) for Barrett’s oesophagus (BE)-related neoplasia is currently used after endoscopic resection of visible neoplasia. The HALO 360 balloon has been used to ablate long segment BE. The Barrx™ 360 Express RFA self-sizing catheter (‘RFA Express’) may potentially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magee, Cormac G., Graham, David, Gordon, Charles, Dunn, Jason, Penman, Ian, Willert, Robert, Smart, Howard, Ortiz-Fernandez-Sordo, Jacobo, Ragunath, Krish, Everson, Martin, Alzoubaidi, Durayd, Banks, Matthew, Morris, Danielle, Sami, Sarmed, Morris, Allan J., Bhandari, Pradeep, Narayanasamy, Ravi, Di Pietro, Massimiliano, Lovat, Laurence B., Haidry, Rehan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741663/ https://www.ncbi.nlm.nih.gov/pubmed/33547491 http://dx.doi.org/10.1007/s00464-021-08325-0

Ejemplares similares

Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s esophagus-related neoplasia
por: Alzoubaidi, Durayd, et al.
Publicado: (2019)

Cryoballoon ablation for treatment of patients with refractory esophageal neoplasia after first line endoscopic eradication therapy
por: Alzoubaidi, Durayd, et al.
Publicado: (2020)

Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009)

Machine Learning Creates a Simple Endoscopic Classification System that Improves Dysplasia Detection in Barrett's Oesophagus amongst Non-expert Endoscopists
por: Sehgal, Vinay, et al.
Publicado: (2018)

Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer
por: Di Caro, Simona, et al.
Publicado: (2016)

Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry
por: Haidry, R J, et al.
Publicado: (2015)

Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience
por: Graham, David, et al.
Publicado: (2018)

Factors influencing participation in randomised clinical trials among patients with early Barrett’s neoplasia: a multicentre interview study
por: Peerally, Mohammad Farhad, et al.
Publicado: (2023)

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

The natural history of low‐grade dysplasia in Barrett's esophagus and risk factors for progression
por: Hussein, Mohamed, et al.
Publicado: (2021)

A new artificial intelligence system successfully detects and localises early neoplasia in Barrett's esophagus by using convolutional neural networks
por: Hussein, Mohamed, et al.
Publicado: (2022)

Endoscopic Management of Dysplastic Barrett’s Oesophagus and Early Oesophageal Adenocarcinoma
por: Eusebi, Leonardo Henry, et al.
Publicado: (2023)

Barrett’s Esophagus and Cancer Risk: How Research Advances Can Impact Clinical Practice
por: di Pietro, Massimiliano, et al.
Publicado: (2014)

Study to investigate the prevalence of human papillomavirus in Barrett’s oesophagus using a novel screening methodology
por: White, Jonathan Richard, et al.
Publicado: (2022)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
por: Jankowski, Janusz A Z, et al.
Publicado: (2018)

Comparative quantitative survey of patient experience in Barrett’s oesophagus and other gastrointestinal disorders
por: Britton, James, et al.
Publicado: (2020)

Diagnosis and management of Barrett’s oesophagus
por: Jankowski, Janusz, et al.
Publicado: (2010)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Barrett’s oesophagus: Current controversies
por: Amadi, Chidi, et al.
Publicado: (2017)

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot
por: Pilonis, Nastazja Dagny, et al.
Publicado: (2022)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

Screening for Barrett's oesophagus: is now the time?
por: Hanada, Yuri, et al.
Publicado: (2020)

Screening for Barrett’s Oesophagus: Are We Ready for it?
por: Yusuf, Aisha, et al.
Publicado: (2021)

The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus
por: di Pietro, Massimiliano, et al.
Publicado: (2015)

Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study
por: Ross-Innes, Caryn S., et al.
Publicado: (2015)

Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus
por: Dunn, J M, et al.
Publicado: (2011)

Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002)

Influence of Life Style Factors on Barrett's Oesophagus
por: Horna Strand, A., et al.
Publicado: (2014)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus
por: Luebeck, Jens, et al.
Publicado: (2023)

Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study
por: Hadjinicolaou, Andreas V., et al.
Publicado: (2020)

Bariatric and Metabolic Endoscopy: A New Paradigm
por: Telese, Andrea, et al.
Publicado: (2021)

Computer-aided characterization of early cancer in Barrett’s esophagus on i-scan magnification imaging: a multicenter international study
por: Hussein, Mohamed, et al.
Publicado: (2023)

Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening
por: Sami, Sarmed S., et al.
Publicado: (2021)

Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003)

Acceptability to patients of screening disposable transnasal endoscopy: qualitative interview analysis
por: McGoran, John, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a4n4f52f6gg4s0sm167diugf6a